You have 9 free searches left this month | to do more

revlimid

Revlimid is a drug used to treat Multiple Myeloma, Lymphoma, Prostate Cancer, and other conditions. Revlimid is being actively studied in 3 studies and prior, has been studied in 12.

Top SponsorsTop SitesTop Investigators
National Cancer Institute (NCI)Duke University Medical CenterCaryn Steakley, R.N.
CelgeneAKH Linz, Innere Medizin 3, Zentrum fur Hamatologie und medizinische OnkologieDr. Sigrun Hallmeyer
Hackensack Meridian HealthASO KK Iizuka HospitalHareth Nahi
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid in Combination With Polatuzumab (ViPOR-P) in Relapsed/Refractory B-cell Lymphoma
Recruiting
  • Lymphoma
  • +3 more
  • obinutuzumab
  • +5 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022
U
Phase II Trial of Revlimid® and Rituximab for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Active, not recruiting
Has Results
  • Chronic Lymphocytic Leukemia
  • CLL
  • La Jolla, California
    University of California, San Diego
2021-09-02
Sep 2, 2021
C
A Non-interventional, Observational Post-marketing Registry of Patients Treated With Revlimid (Lenalidomide) in Taiwan - 2013
Completed
  • Multiple Myeloma
  • Revlimid
  • Taipei, Taiwan
    NTUH
2019-11-14
Nov 14, 2019
N
Carfilzomib, Lenalidomide, and Dexamethasone for Smoldering Multiple Myeloma
Active, not recruiting
  • Multiple Myeloma
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
2022-04-07
Apr 7, 2022
C
Revlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL)
Unknown status
  • Lymphoma
  • Revlimid
  • Iizuka, Fukuoka, Japan
    ASO KK Iizuka Hospital
2019-09-11
Sep 11, 2019
S
Study of 2 Different Doses of Revlimid in Biochemically Relapse Prostate Cancer - 2016
Completed
Has Results
  • Prostate Cancer
  • Revlimid
  • Baltimore, Maryland
    The Harry and Jeanette Weinberg Building
2019-04-11
Apr 11, 2019
R
R2 in the Treatment of Follicular Lymphoma
Unknown status
  • Follicular Lymphoma
  • Revlimid
  • Shanghai, Shanghai, China
    Ruijin Hospital
2019-07-04
Jul 4, 2019
N
A Trial Evaluating Efficacy & Safety of RVD +/- Panobinostat in Transplant Eligible, Newly Diagnosed Multiple Myeloma (NDMM) - 2017
Terminated
Has Results
  • Multiple Myeloma
  • Revlimid
  • +3 more
  • Los Angeles, California
  • +4 more
2018-06-26
Jun 26, 2018
D
Velcade + Cyclophosphamide in Newly Diagnosed Multiple Myeloma - 2016
Terminated
Has Results
  • Multiple Myeloma
  • Durham, North Carolina
    Duke University Medical Center
2017-04-26
Apr 26, 2017
U
Study of Lenalidomide in Relapse/Refractory Waldenstrom Macroglobulinemia - 2017
Completed
  • Waldenstrom Macroglobulinemia
  • Revlimid
  • Bayonne, France
  • +6 more
2017-06-06
Jun 6, 2017
N
Lenalidomide (Revlimid) to Treat Advanced Ocular Melanoma - 2009
Completed
Has Results
  • Melanoma
  • Revlimid
  • Bethesda, Maryland
    National Cancer Institute (NCI)
2016-11-14
Nov 14, 2016
K
Randomized Trial Comparing Lenalidomide With Low Dose Dexamethasone Versus Lenalidomide in Second Line Multiple Myeloma
Completed
  • Multiple Myeloma
  • Revlimid
  • Stockholm, Sweden
  • +1 more
2016-03-24
Mar 24, 2016
P
Study of Treatment for Newly Diagnosed Multiple Myeloma Patients Older Than 65 Years With Sequential Melphalan/Prednisone/Velcade (MPV) Followed by Revlimid/Low Dose Dexamethasone (Rd) Versus Alternating Velcade/Melphalan/Prednisone (MPV) With Revlimid/Low Dose Dexamethasone - 2016
Completed
  • Multiple Myeloma
  • Palma de Mallorca, Baleares, Spain
  • +62 more
2017-01-16
Jan 16, 2017
U
UARK 2009-09 Myeloma Cure Project: Prospective Trial of Indefinite Revlimid Maintenance Versus Observation for Currently Event-Free Patients With Multiple Myeloma - 2014
Completed
Has Results
  • Multiple Myeloma
  • Revlimid
  • Little Rock, Arkansas
    University of Arkansas for Medical Science-MIRT
2015-09-29
Sep 29, 2015
U
Maintenance Therapy in Acute Myeloid Leukemia (AML) Patients - 2015
Completed
  • Acute Myeloid Leukemia
  • Revlimid
  • Toronto, Ontario, Canada
    University Health Network, Princess Margaret Hospital
2015-06-17
Jun 17, 2015
M
Lenalidomide and Gemcitabine as First-line Treatment in Patients With Pancreatic Cancer - 2014
Completed
  • Pancreatic Carcinoma.
  • Stockholm, Solna, Sweden
    Karolinska University Hospital
2014-11-26
Nov 26, 2014
A
Lenalidomide in Patients With Chronic Myelomonocytic Leukemia
Unknown status
  • Chronic Myelomonocytic Leukemia
  • Revlimid
  • Linz, Oberösterreich, Austria
  • +9 more
2015-03-06
Mar 6, 2015
O
Study Evaluating Toxicity & Efficacy of Lenalidomide(Revlimid®)in Chemotherapy-Naïve AIPC Patients - 2012
Completed
Has Results
  • Prostate Cancer
  • Revlimid
  • Niles, Illinois
  • +1 more
2014-02-28
Feb 28, 2014
H
Study of Lenalidomide in Combination With RICE With Lenalidomide Maintenance Post-Auto Transplant for DLBCL
Unknown status
  • Diffuse Large B-cell Lymphoma.
  • Revlimid
  • Hackensack, New Jersey
  • +1 more
2014-02-02
Feb 2, 2014
M
Revlimid in Patients With Acute Myelogenous Leukemia and Myelodysplastic Syndrome - 2012
Completed
Has Results
  • Acute Myelogenous Leukemia
  • Myelodysplastic Syndrome
  • Revlimid
  • Houston, Texas
    UT MD Anderson Cancer Center
2013-08-05
Aug 5, 2013
H
Study Examining the Combination of Lenalidomide and Azacitidine for Relapsed/Refractory CLL and SLL - 2011
Terminated
  • Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL)
  • Hackensack, New Jersey
    Hackensack University Medical Center
2012-11-07
Nov 7, 2012
U
Evaluation of Lenalidomide, Doxorubicin and Dexamethasone (RAD) in Patients With Relapsed or Refractory Multiple Myeloma
Completed
  • Relapse
  • Refractory Multiple Myeloma
  • Revlimid
  • Wuerzburg, Bavaria, Germany
    Dept. of Internal Medicine II, University of Wuerzburg
2009-08-03
Aug 3, 2009